Xcout Intel
MycoRx LLC competitors & alternatives
The 12 closest competitors and alternatives to MycoRx LLC among biotechnology companies — ranked by similarity to what MycoRx LLC actually does, not by market-cap band.
Subscribe to see MycoRx LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About MycoRx LLC
MycoRx LLC develops new antifungal drug candidates designed to overcome drug resistance and treat fungal infections ranging from recurrent skin conditions to life-threatening sepsis. The company also supports clinical trials for other drug developers and maintains safety standards in the testing and manufacturing of pharmaceutical products.
MycoRx LLC at a glance
MycoRx LLC is a biotechnology company headquartered in United States. Its most recent funding round raised $600,000 in April 2026. Xcout tracks 1 named person at MycoRx LLC, including Abhiram Maddi (Executive Officer).
MycoRx LLC leadership
- Abhiram MaddiExecutive Officer
MycoRx LLC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $600,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 MycoRx LLC competitors
Ranked by semantic similarity — how close each company is to MycoRx LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Pikralida is a biotechnology and contract research organization located in Poland that combines research, development, and innovative formulation services to advance breakthrough therapeutics.
Similar biotechnology company
Remedy Plan, Inc. is a Maryland-based biotechnology holding company founded in 2011 that focuses on drug pipelines, patents, and clinical trials.
Pharmaceuticals
SFJ Pharmaceuticals is a privately held pharmaceutical development and investment company that helps advance drug candidates through clinical development and regulatory approval. It serves biotechnology and pharmaceutical partners by providing development funding, operational expertise, and global clinical-trial support.
Biotech
Amplyx Pharmaceuticals, Inc. was a San Diego-based clinical-stage biotechnology company developing treatments for serious and potentially life-threatening fungal infections. Its lead investigational drug, fosmanogepix, was acquired by Pfizer when Pfizer acquired Amplyx in 2021 and is being developed for patients with invasive fungal diseases.
Similar biotechnology company
Alopexx, Inc. is a U.S. biotechnology company developing broad-spectrum anti-infective vaccines and antibody-based therapies. Its programs target PNAG, a surface polysaccharide found on many bacterial and fungal pathogens, for potential treatment or prevention of serious infections.
Similar biotechnology company
AMR Bio is a clinical-stage biotechnology company headquartered in London, United Kingdom, focused on infection prevention and antimicrobial resistance. The company is dedicated to developing novel anti-infectives, including its Phase 3-ready, first-in-class topical antimicrobial candidate XF-73.
Similar biotechnology company
Ichor Biotechnologies, Inc. operates as a pre-clinical contract research organization (CRO) that provides laboratory and research services to biotechnology and pharmaceutical companies. The company offers protein services, pharmacology services, in vivo disease models, and clinical trial support to assist clients with drug discovery and development.
Biotech
Omnix Medical is a biopharmaceutical company that develops novel antibiotic agents and antimicrobial peptides to treat infections caused by drug-resistant bacteria. The company focuses on creating first-in-its-class anti-infective therapeutics, such as its lead compound OMN6, to target life-threatening bacterial strains.
Similar biotechnology company
Evrys Bio, LLC is a biotechnology company developing first-in-class therapeutics designed to treat a broad spectrum of viral infections and prevent drug resistance. The company utilizes allosteric, small molecule SIRT2 modulators that target host cells to suppress viral infections and shift metabolic reprogramming.
Similar biotechnology company
C3J Therapeutics, Inc. is a clinical-stage biotechnology company based in Los Angeles, California, focused on improving human health through the development of targeted antimicrobials.
Similar biotechnology company
Oragenics, Inc. is a biotechnology development-stage company incorporated in Florida in 1996 and headquartered in Lakewood Ranch, Florida. It is dedicated to fighting infectious diseases, including coronaviruses and multidrug-resistant pathogens.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of MycoRx LLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for MycoRx LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →